Latest Advances in Nanoparticles for Modern Biomedicine (2nd Edition)
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Nanoscience".
Deadline for manuscript submissions: 30 October 2024 | Viewed by 54
Special Issue Editor
Interests: drug delivery; nanoparticles; nanotechnology; magnetic particles; magnetic separation
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
In the ever-evolving landscape of modern biomedicine, nanoparticles stand at the forefront, heralding new possibilities not only in cancer therapy but also in the broader fields of regenerative medicine and diagnostics. This nuanced approach is the cornerstone of our upcoming Special Issue in the International Journal of Molecular Sciences, titled “Latest Advances in Nanoparticles for Modern Biomedicine 2.0”.
Our focus extends across a spectrum of nanoparticle types, from lipid-based nanoparticles that excel in biocompatibility to solid nanoparticles known for their robustness. Each type offers unique advantages in specific biomedical applications. Particularly noteworthy is the ability of nanoparticles to be engineered for selective targeting, utilizing binding proteins that recognize specific surface regions. These nanoparticles enhance our capabilities in targeted drug delivery and diagnostics, enabling precise treatments and detailed imaging that cater to a diverse array of medical conditions beyond oncology.
This issue will explore the synthesis, characterization, and functionalization of various nanoparticles, highlighting their applications not only in nanotheranostics but also in groundbreaking nanoformulations for both therapeutic and diagnostic uses. We will particularly emphasize the potential of nanoparticles in regenerative medicine, a promising area where their ability to modulate biological processes can significantly impact tissue engineering and healing.
Furthermore, the selective targeting of nanoparticles will be a focal point, facilitated by binding proteins capable of recognizing specific cellular markers. This precision targets the delivery and action of therapeutic agents, avoiding the notion that nanoparticles are a one-size-fits-all solution. Instead, we advocate for a tailored approach where the functional properties of nanoparticles are matched to specific clinical needs.
Guiding this exploration are Dr. Sebastian Schwaminger and Dr. Marco Eigenfeld from the Medical University of Graz, whose expertise is crucial in navigating the complex landscape of nanoparticle-enhanced biomedicine.
We invite contributions that showcase innovative nanoparticle applications, particularly those that explore their diverse functionalities in diagnosis, drug delivery, and beyond, aligning with the broad spectrum of modern biomedical challenges.
Dr. Sebastian Schwaminger
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanoparticles
- nanotherapeutics
- nanomedicine
- biomedicine
- selective targeting of nanoparticles
